Aptivus and Pregnancy
In animal studies on Aptivus and pregnancy, the medication caused bone problems and low fetal weight when it was given to pregnant rabbits. Healthcare providers should only prescribe the drug to pregnant women if the benefits outweigh any possible risks to the unborn child. If you are taking Aptivus and pregnancy occurs, your healthcare provider will weigh the benefits and risks in your particular situation.
Aptivus® (tipranavir) is a prescription AIDS and HIV medication. It belongs to a group of medications known as protease inhibitors. Based on information from animal studies, Aptivus may not be safe for use during pregnancy.
The U.S. Food and Drug Administration (FDA) uses a category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category C is given to medicines that have not been studied in pregnant humans but that do appear to cause harm to the fetus in animal studies. Also, medicines that have not been studied in any pregnant women or animals are automatically given a pregnancy Category C rating.
When given to pregnant rabbits, Aptivus caused bone problems and low fetal weight. However, it is important to note that animals do not always respond to medicines the same way that humans do. Therefore, a pregnancy Category C medicine may be given to a pregnant woman if her healthcare provider believes that the benefits to the woman outweigh any possible risks to the unborn child.
If you are pregnant or are thinking of becoming pregnant while taking Aptivus, let your healthcare provider know. He or she will consider both the benefits and risks of using the drug during pregnancy before making a recommendation in your particular situation. Be sure to seek early prenatal care, as women with HIV or AIDS need special care, both for themselves and their babies.